Indicated for the treatment of

  • active rheumatoid arthritis in adult patients
  • polyarthritic forms of severe, active juvenile idiopathic arthritis (JIA), when the response to nonsteroidal anti-inflammatory drugs (NSAIDs) has been inadequate
  • severe recalcitrant disabling psoriasis, which is not adequately responsive to other forms of therapy such as phototherapy, psoralens and ultraviolet A (PUVA), and retinoids, and severe psoriatic arthritis in adult patients

Available in Sweden, Norway and Finland.

By using this site you agree that we use cookies in accordance with our Cookie policy.

I understand and accept